A Phase II Study Of Sunitinib And Low Dose Metronomic Cyclophosphamide In Advanced Renal Cell Cancer.
Phase of Trial: Phase II
Latest Information Update: 21 May 2014
At a glance
- Drugs Sunitinib (Primary) ; Cyclophosphamide
- Indications Renal cell carcinoma
- Focus Adverse reactions; Therapeutic Use
- Acronyms SUN-CYCL
- 21 Jun 2012 Companies added in the association field as reported by EudraCT.
- 07 Jun 2011 New trial record